Liver Fibrosis-Novel Therapy Perspective
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2017, Vol 1, Issue 7
Abstract
Liver fibrosis is highly prevalent in United States. No therapy has been successful to cure it so far. The current approaches in treatment are to prevent its causative etiology such as viral infection, alcohol abuse etc. or liver transplantation. Much progress has been made to understand the mechanisms for development of myofibroblasts in developing fibro genesis, inflammation and cell death. This review summarizes some of the key aspects of liver fibrosis and some novel therapies that have a potential to become a cure.
Authors and Affiliations
Panakanti R*
Symptoms, Precaution and Prevention for COVID-19
In early 2020, another infection started creating features everywhere throughout the world in light of the exceptional speed of its transmission. Its inceptions have been followed to a food showcase in Wuhan, China, in...
An Updated Review on Self Emulsifying Drug Delivery System
Solubility of orally administered drug is major obstacle of pharmaceutical industry as nearly 35-40% of newly discovered drugs substancehave low aqueous solubility which results in their poor dissolution and bioavailabi...
Optimization and Formulation Design with In-Vitro Evaluation of Fast Disintegrating Tablets Containing Candesartan Solid Dispersions
The aim of this study was to assess the effects of processing parameters on the release of solid dispersion formulation from a fast dissolving tablet dosage form. Graphical and mathematical analysis such as the response...
Pharmacovigilance - Shaping the Present and Future of Medicines
Pharmacovigilance has an important role in detecting adverse drug reactions. The success of the programme depends on the knowledge and attitude of the involved professionals. Strong Pharmacovigilance programme will help...
Transferosomes for Trans-Nasal Brain Delivery of Clonazepam Preparation Optimization Ex Vivo Cytotoxicity and Pharmacodynamic Study
Clonazepam (CZ) is a benzodiazepine derivative that is used mainly in the treatment of status epilepticus (SE). Intranasal (IN) administration of nano-carrier systems generally have the ability to deliver the drug to the...